CAPA has partnered with 23 patient organizations to write a letter to the Minister of Health strongly supporting the decision that Minister announced on April 14th, 2022 with regards to the Amendments to the Patented Medicines Regulations providing new tools to...
Access to the right medicines is an important component in managing arthritis. In Canada, the Patented Medicines Prices Review Board (PMPRB) plays a key role in drug pricing in Canada. On July 1, 2020, the newly amended Patented Medicines Regulations will come into...
